Answer
Patients should be observed for at least 30 minutes after receiving Clariscan (gadoterate meglumine), since most undesirable effects occur within this time.
Sources for this answer
- Clariscan 0.5 mmol/ mL solution for injectionGE Healthcare Limited · emc · SmPC §4.2 Posology and method of administration · Version 5Document updated
Sources checked